Yestar Healthcare Holdings Company Limited (HKG:2393)
Hong Kong
· Delayed Price · Currency is HKD 0.0770
-0.0020 (-2.53%)
May 2, 2025, 3:35 PM HKT
HKG:2393 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2,410 | 2,913 | 2,805 | 4,931 | 4,107 | Upgrade
|
| Revenue Growth (YoY) | -17.26% | 3.86% | -43.12% | 20.06% | -16.24% | Upgrade
|
| Cost of Revenue | 2,011 | 2,400 | 2,407 | 4,082 | 3,300 | Upgrade
|
| Gross Profit | 399.2 | 512.78 | 397.55 | 848.7 | 806.88 | Upgrade
|
| Selling, General & Admin | 362.41 | 380.58 | 364.9 | 657.01 | 623.46 | Upgrade
|
| Other Operating Expenses | 180.49 | - | - | - | - | Upgrade
|
| Operating Expenses | 519.06 | 341.74 | 504.38 | 664.33 | 648.74 | Upgrade
|
| Operating Income | -119.86 | 171.04 | -106.83 | 184.37 | 158.14 | Upgrade
|
| Interest Expense | -30.16 | -164.71 | -273.14 | -127.79 | -124.08 | Upgrade
|
| Interest & Investment Income | 1.49 | 2.39 | 4.96 | 8.25 | 11.35 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 7.99 | 5.25 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 10.03 | - | 11.43 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.26 | 7.2 | 2.58 | -7.39 | 17.75 | Upgrade
|
| EBT Excluding Unusual Items | -153.8 | 15.93 | -362.39 | 65.43 | 79.84 | Upgrade
|
| Impairment of Goodwill | - | - | -1.44 | - | -447.45 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.03 | 0.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.03 | 0.41 | 0.34 | 0.91 | 17.55 | Upgrade
|
| Asset Writedown | - | - | -121.29 | -41.58 | -342.86 | Upgrade
|
| Other Unusual Items | 1,083 | 24.71 | - | 35.16 | - | Upgrade
|
| Pretax Income | 929.64 | 41.04 | -484.78 | 59.94 | -692.6 | Upgrade
|
| Income Tax Expense | 26.67 | 39.56 | -10.83 | 47.26 | -47.3 | Upgrade
|
| Earnings From Continuing Operations | 902.98 | 1.48 | -473.95 | 12.68 | -645.3 | Upgrade
|
| Earnings From Discontinued Operations | 0.54 | -4.57 | -531.92 | - | - | Upgrade
|
| Net Income to Company | 903.51 | -3.09 | -1,006 | 12.68 | -645.3 | Upgrade
|
| Minority Interest in Earnings | 18.1 | -10.79 | 13.63 | -9.35 | 54.81 | Upgrade
|
| Net Income | 921.61 | -13.89 | -992.23 | 3.33 | -590.49 | Upgrade
|
| Net Income to Common | 921.61 | -13.89 | -992.23 | 3.33 | -590.49 | Upgrade
|
| Shares Outstanding (Basic) | 2,332 | 2,332 | 2,332 | 2,347 | 2,362 | Upgrade
|
| Shares Outstanding (Diluted) | 2,332 | 2,332 | 2,332 | 2,347 | 2,362 | Upgrade
|
| Shares Change (YoY) | - | - | -0.64% | -0.64% | -1.21% | Upgrade
|
| EPS (Basic) | 0.40 | -0.01 | -0.43 | 0.00 | -0.25 | Upgrade
|
| EPS (Diluted) | 0.40 | -0.01 | -0.43 | 0.00 | -0.25 | Upgrade
|
| Free Cash Flow | -26.45 | 292.54 | -115.58 | 665.55 | 591.92 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.13 | -0.05 | 0.28 | 0.25 | Upgrade
|
| Gross Margin | 16.56% | 17.61% | 14.17% | 17.21% | 19.65% | Upgrade
|
| Operating Margin | -4.97% | 5.87% | -3.81% | 3.74% | 3.85% | Upgrade
|
| Profit Margin | 38.24% | -0.48% | -35.38% | 0.07% | -14.38% | Upgrade
|
| Free Cash Flow Margin | -1.10% | 10.04% | -4.12% | 13.50% | 14.41% | Upgrade
|
| EBITDA | -72.29 | 238.97 | 14.71 | 315.89 | 305.49 | Upgrade
|
| EBITDA Margin | -3.00% | 8.20% | 0.52% | 6.41% | 7.44% | Upgrade
|
| D&A For EBITDA | 47.57 | 67.93 | 121.54 | 131.52 | 147.35 | Upgrade
|
| EBIT | -119.86 | 171.04 | -106.83 | 184.37 | 158.14 | Upgrade
|
| EBIT Margin | -4.97% | 5.87% | -3.81% | 3.74% | 3.85% | Upgrade
|
| Effective Tax Rate | 2.87% | 96.40% | - | 78.85% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.